Assignee for the Benefit of Creditors Solstice Biologics was developing drugs aimed at small, cell permeable RNAi pro-drugs. The company located in San Diego, California received several rounds of funding, but was never able to reach revenue generation and the research and development activity was discontinued. DSI Assignments, LLC was name as the Assignee for […]
30 April, 2024
Assignee for the Benefit of Creditors DSI has acted as the assignee for the benefit of creditors of this San Diego, CA, based biotech firm. API developed software to analyze proteins and hundreds to thousands of biological features (pieces of proteins) through upgraded mass spectrometry. The API was initially funded by a private equity firm […]
30 April, 2024